2222. A study of the role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatment: An open-labeled, randomized controlled trial

BACKGROUND: Individuals with lupus are at risk of opportunistic infections (OIs), especially pneumocystis pneumonia and nocardiosis. The current recommendation to prevent OIs is to take trimethoprim-sulfamethoxazole (TMP/SMX) regularly while on treatment for lupus. However, there has yet to be a sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Munthananuchat, Paopat, Ngamjanyaporn, Pintip, Pisitkun, Prapaporn, Rotjanapan, Porpon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679281/
http://dx.doi.org/10.1093/ofid/ofad500.1844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679281/
http://dx.doi.org/10.1093/ofid/ofad500.1844

Ejemplares similares